Dean Tuck – Managing Director – Dreadnought Resources (ASX:DRE) is a highly active West Australian mineral explorer focused on finding the metals needed now and in the future.
Copyright 2023 – Finance News Network
17 May 2023 - QX Resources Limited (ASX:QXR) Managing Director Steve Promnitz discusses the company's letter of intent with Liberty Lithium, the advantages of the project, the difference between brine and hard rock lithium, and the timeline ahead.
14 Jun 2023 - Australia holds the world's third largest amount of vanadium, behind China and Russia, but does not supply this critical mineral into the global market. Project Director Peter Hedley from Richmond Vanadium Technology (ASX:RVT) discusses the company's progress and the vanadium industry.
27 Aug 2021 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes provides an update on sales and distribution for the company's Automated Plate Assessment System (APAS), which is used to read culture plates in laboratories.
25 Feb 2020 - Noxopharm Limited (ASX:NOX) Chief Medical Officer, Dr Gisela Mautner, talks about results from the company's LuPIN trial in prostate cancer, evaluating its lead product candidate, Veyonda, in combination with 177Lu-PSMA-617, a radiopharmaceutical therapy, in 56 patients with late-stage prostate cancer.
07 Nov 2023 - Newly appointed Lincoln Minerals (ASX:LML) CEO Jonathon Trewartha discusses their focus on developing the Kookaburra Gully Graphite Project in South Australia. He highlights plans to expand the resource through drilling, aiming for a 10-year mine life, and addresses the company's response to global market changes impacting graphite production.
04 Nov 2019 - Altura Mining (ASX:AJM) Managing Director James Brown, talks about its rights issue to raise $21M, production at its Pilgangoora mine in the Pilbara and outlook for lithium demand.
03 February 2021 - Nyrada Limited (ASX:NYR) CEO James Bonnar talks about the company's collaboration agreement with the Walter Reed Army Institute of Research and UNSW into the study of a first-ever pharmaceutical treatment for traumatic brain injury, a top health priority for the military.
18 May 2022 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow provides an update on clinical trial progression, and discusses recent agreements with WuXi Advanced Therapies and Be The Match BioTherapies.